We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$4.21B
AUM Growth
+$243M
Cap. Flow
+$12.7M
Cap. Flow %
0.3%
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$20.5M
2
NFLX icon
Netflix
NFLX
+$19.9M
3
COST icon
Costco
COST
+$18.6M
4
IBM icon
IBM
IBM
+$17.9M
5
PLTR icon
Palantir
PLTR
+$17.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$19.1M
2
QCOM icon
Qualcomm
QCOM
+$19.1M
3
CMCSA icon
Comcast
CMCSA
+$19.1M
4
INTC icon
Intel
INTC
+$19.1M
5
UPS icon
United Parcel Service
UPS
+$19M

Sector Composition

Rank Sector Weight
1 Financials 28.41%
2 Consumer Discretionary 12.52%
3 Industrials 11.69%
4 Technology 11.49%
5 Energy 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OVID icon
1151
Ovid Therapeutics
OVID
$489M
$31.5K ﹤0.01%
95,434
– –
BRLT icon
1152
Brilliant Earth
BRLT
$16.9M
$31.2K ﹤0.01%
22,800
– –
QVCGA
1153
DELISTED
QVC Group Inc Series A
QVCGA
$30.5K ﹤0.01%
11,081
-265
-2% -$1.52K
FATE icon
1154
Fate Therapeutics
FATE
$303M
$28K ﹤0.01%
+25,000
New +$29.1K
ACRV icon
1155
Acrivon Therapeutics
ACRV
$70.2M
$27.3K ﹤0.01%
22,900
-55,000
-71% -$75.5K
FBLG icon
1156
FibroBiologics
FBLG
$5.28M
$24.9K ﹤0.01%
2,000
-1,750
-47% -$31.6K
RANI icon
1157
Rani Therapeutics
RANI
$87.7M
$23.9K ﹤0.01%
46,500
– –
OPAD icon
1158
Offerpad Solutions
OPAD
$21.8M
$23.1K ﹤0.01%
2,540
– –
SMXT icon
1159
Solarmax Technology
SMXT
$22.1M
$22K ﹤0.01%
20,200
-4,800
-19% -$5.45K
VIP
1160
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$39.2M
$21.9K ﹤0.01%
17,000
– –
GURE
1161
Gulf Resources
GURE
$4.68M
$21.7K ﹤0.01%
3,236
– –
STRR
1162
DELISTED
Star Equity Holdings
STRR
$21.2K ﹤0.01%
10,678
– –
GPRO icon
1163
GoPro
GPRO
$125M
$18.6K ﹤0.01%
24,500
-290,000
-92% -$188K
SSY
1164
DELISTED
SunLink Health Systems
SSY
$17.4K ﹤0.01%
19,795
-75,383
-79% -$68.5K
GRWG icon
1165
GrowGeneration
GRWG
$88.9M
$17.3K ﹤0.01%
18,497
– –
LGL.WS
1166
DELISTED
LGL Group Inc Warrants
LGL.WS
$16.9K ﹤0.01%
29,200
– –
TBHC
1167
DELISTED
The Brand House Collective
TBHC
$16.6K ﹤0.01%
15,400
– –
MSN icon
1168
Emerson Radio
MSN
$7.8M
$16K ﹤0.01%
47,100
– –
IPSC icon
1169
Century Therapeutics
IPSC
$353M
$14.9K ﹤0.01%
26,700
-93,800
-78% -$50.3K
TPIC
1170
DELISTED
TPI Composites
TPIC
$12.5K ﹤0.01%
14,600
– –
NOTE
1171
DELISTED
FiscalNote
NOTE
$12.3K ﹤0.01%
1,908
-12,917
-87% -$96.8K
CARM
1172
DELISTED
Carisma Therapeutics
CARM
$12.1K ﹤0.01%
30,988
– –
TNYA icon
1173
Tenaya Therapeutics
TNYA
$170M
$12.1K ﹤0.01%
19,800
– –
MPTI.WS
1174
DELISTED
M-tron Industries Warrants
MPTI.WS
$11.7K ﹤0.01%
+11,334
New +$13K
UBX
1175
DELISTED
Unity Biotechnology
UBX
$9.5K ﹤0.01%
25,000
-25,000
-50% -$21.4K
45 46
47
48 49

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Bridgeway Capital Management held 1,288 positions worth $4.21B, up 6.1% from $3.97B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Bridgeway Capital Management's Q2 2025 filing shows 116 new, 426 increased, 381 reduced and 108 closed positions. Its largest new stake was AbbVie: 110,140 shares worth $20.4M. The largest sale was Pfizer, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q2 2025 buy was AbbVie: 110,140 shares worth $20.4M.
  • Bridgeway Capital Management added most to Costco in Q2 2025, an estimated $18.6M increase.
  • Bridgeway Capital Management's biggest Q2 2025 reduction was Gulfport Energy Corp, cutting an estimated $14.8M.
  • Bridgeway Capital Management fully exited Pfizer in Q2 2025, selling an estimated $19.1M.
  • Bridgeway Capital Management's ten largest holdings make up 8.2% of its $4.21B portfolio in Q2 2025.
  • Bridgeway Capital Management opened 116 new positions and closed 108 in Q2 2025.
  • Bridgeway Capital Management's portfolio value rose 6.1% quarter-over-quarter to $4.21B.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.